Vascular dementia, a new beginning: Shifting focus from clinical phenotype to ischemic brain injury

Neurologic Clinics

Volumn 18, Issue 4, 2000, Pages 951-977

  Chui, Helena ^b  

^a RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DONEPEZIL; MEMANTINE; NOOTROPIC AGENT; PENTOXIFYLLINE; PIRACETAM;

BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; GRAY MATTER; HUMAN; INCIDENCE; MULTIINFARCT DEMENTIA; NEURORADIOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCORING SYSTEM; STROKE; WHITE MATTER;

EID: 0034523169     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70234-6     Document Type: Article

References (110)

1. Neuropsychological deficits in vascular dementia in relation to Alzheimer's disease: Reviewing evidence for functional similarity or divergence
2. Die arteriosklerotische Atrophie de Gehirns
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
4. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis
5. Die Abgrenzung der allgemeinen progressiven Paralyse
6. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect
7. Oxiracetam in dementia: A double-blind, placebo-controlled study
8. Brain MR: Pathologic correlation with gross and histopathology. I: Lacunar infarction and Virchow-Robin spaces
9. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
10. Stroke incidence, prevalence and survival: Secular trends in Rochester, Minnesota through 1989
11. Binswanger's disease: Revisited
12. Introduction to evidence-based diagnosis of dementia
13. Rethinking vascular dementia: Moving from myth to mechanism
14. Subcortical ischemic lesions in dementia are associated with hippocampal and cortical atrophy
15. Clinical diagnostic criteria
16. Clinical criteria for the diagnosis of vascular dementia: A multi-center study of comparability and interrater reliability
17. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer Disease Diagnostic and Treatment Centers (ADDTC)
18. The subacute stroke patient: Preventing recurrent stroke
19. Blood pressure, antihypertensive drug treatment and the risks of stroke and of heart disease
20. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults
21. Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons
22. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats
23. The human periventricular arterial blood supply and the anatomy of cerebral infarctions
24. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy
25. Recovery of cognitive function after stroke
26. White matter changes in dementia of Alzheimer's type
27. Accuracy of the clinical diagnosis of vascular dementia: A prospective clinical and post-mortem neuropathological study
28. European Pentoxifylline multi-infarct dementia study
29. Therapeutic efficacy of vincamine in dementia
30. Dementia in cerebrovascular disease
31. Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia
32. Ischemic stroke and incomplete infarction
33. The subacute stroke patient: Blood pressure management
34. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia
35. Prevention of first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
36. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State: The Kame Project
37. Effect of antihypertensive treatment in patients having already suffered from stroke: Gathering the evidence
38. Vascular dementia: A radical redefinition
39. Vascular dementia: The need for a new approach
40. Cerebral blood flow in dementia
41. Multi-infarct dementia: A cause of mental deterioration in the elderly
42. Leuko-araiosis
43. Cumulative white matter changes in the gerbil brain under chronic cerebral hypoperfusion
44. Flow thresholds of functional and morphological damage of brain tissue
45. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia
46. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
47. Anatomic neuroimaging in the dementias
48. User's guide to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid?
49. User's guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?
50. Clinicopathological analysis of dementia disorders in the elderly
51. The prevalence of dementia: A quantitative integration of the literature
52. Proof of efficacy of the Gingko biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
53. Clinical trials of propentofylline in vascular dementia
54. Vascular lesions in dementia: A population-based study in Rochester, Minn., 1985-1989
55. Neuropathologic changes in the gerbil brain after chronic hypoperfusion
56. Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type
57. Management of hypertension for stroke prevention in older people
58. Presence and severity of white matter lesions and hypertension, its treatment, and its control. The ARIC study
59. Intellectual impairment and cerebral lesions in multiple cerebral infarcts: A clinical-computed tomography study
60. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people
61. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people
62. Differentiation of vascular dementia from AD on neuropsychological tests
63. Improved cognition after control of risk factors for multi-infarct dementia
64. Controlled clinical trial of daily aspirin therapy in multi-infarct dementia
65. Leukoaraiosis in relation to prognosis for patients with lacunar infarction
66. Pharmacologic rationale for memantine in chronic cerebral hypoperfusion, especially vascular dementia
67. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: An anatomic study
68. Does tortuosity in cerebral arterioles impair down-autoregulation in hypertensives and elderly normotensives? A hypothesis and computer model
69. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias
70. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging
71. Experimental basis of multi-infarct dementia: Memory impairments in rodent models of ischemia
72. Decreased signal intensity of cerebral cortex on T2-weighted MRI
73. Pathogenesis of leukoaraiosis: A review
74. Mild cognitive impairment: Clinical characterization and outcome
75. Dementia three months after stroke: Baseline frequency and effect of different definitions of dementia in the Helskinki stroke aging memory study (SAM) cohort
76. Hemodynamics and metabolism in ischemic cerebrovascular disease
77. Practice parameters for diagnosis and evaluation of dementia
78. Infraputaminal "lacunes": Clinical and pathological correlations
79. The prevalence of vascular dementia in Europe: Fact and fragments from 1980-1990 studies
80. Frequency and distribution of vascular dementia
81. Decreased cerebral blood flow precedes multi-infarct dementia, but follows senile dementia of the Alzheimer type
82. Propentofylline in the treatment of Alzheimer's disease and vascular dementia: A review of Phase III trials
83. Senile dementia of the Binswanger type: A vascular form of dementia in the elderly
84. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN Internation Workshop
85. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the atherosclerosis risk in communities (ARIC) cohort
86. Systolic blood pressure within an intermediate range may reduce memory loss in an elderly hypertensive cohort
87. Relations between symptomatology and brain function in dementias: Double-blind, placebo-controlled clinical and EEG/ERP mapping studies with nicergoline
88. Propentophylline in adult-onset cognitive disorders: Double-blind, placebo-controlled, clinical, psychometric and brain mapping studies
89. Meta-analysis of hydergine clinical trials in primary dementia
90. Silent cerebrovascular disease in the elderly: Correlation with ambulatory pressure
91. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease
92. Regulation of cerebral blood flow in health and disease
93. The subacute stroke patient: Lipid management
94. Prevalence of dementia after stroke depends on diagnostic criteria
95. Dementia associated with cerebrovascular disease, other degenerative diseases and metabolic disorders
96. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia
97. Comparison of seven sets of criteria used for the diagnosis of vascular dementia
98. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN)
99. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study
100. Progression of callosal atrophy with deterioration of cerebral oxygen metabolism after carotid artery occlusion
101. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type
102. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study